Following FDA approval earlier this year, Rezzayo (Rezafungin acetate) became the initial drug authorized for candidemia and invasive candidiasis treatment in over a decade.from Medindia Health News https://ift.tt/jnW47wu
via
Following FDA approval earlier this year, Rezzayo (Rezafungin acetate) became the initial drug authorized for candidemia and invasive candidiasis treatment in over a decade.from Medindia Health News https://ift.tt/jnW47wu
via
No comments:
Post a Comment